Osbon Capital Management »

Alnylam Pharmaceuticals shares owned by Osbon Capital Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Osbon Capital Management from 13F filings

Historical chart of Osbon Capital Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Osbon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Osbon Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.2k 18 397.67

More positions owned by Osbon Capital Management

Vanguard World Fd Inf Tech Etf Cl A Com (VGT)
Vanguard Index Fds Vanguard Total Stk Mkt Etf Value Etf (VTI)
Invesco Qqq Tr Unit Ser 1 Shs Ben Int (QQQ)
Ishares Tr Rus 1000 Grw Etf Rus 2000 Grw Etf (IWF)
wisdomtreetrusdivd.. (DGRW)
Spdr S&p500 Etf Trust Trust Unit Depositary Receipt State Street Spd (SPY)
Ishares Tr Ishares Semicdtr Msci Intl Qualty (SOXX)
Vanguard Small-cap Index Fund Div App Etf (VB)
Cloudflare Inc Cl A Cl A Com (NET)
Blackstone Secd Lending Common Stock (BXSL)
Vaneck Etf Trust Semiconductr Etf Van Ftse Dev Mkt (SMH)
Grayscale Bitcoin Ord (GBTC)
Microsoft Corp Com Cl A (MSFT)
Golub Capital BDC (GBDC)
Apple (AAPL)

View all positions for Osbon Capital Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Invesco
Dodge & Cox
Wellington Management Company
T. Rowe Price Investment Management
Orbis Allan Gray

View all funds holding Alnylam Pharmaceuticals